Both in Biotechnology
Protalix BioTherapeutics vs Anavex Life Sciences
Over the past year PLX returned +24.5% and AVXL returned −72.7%; their daily moves had a correlation of 0.12.
PLX +24.5% AVXL −72.7%Growth of $1, one year, split-adjusted
| Metric | PLX | AVXL |
|---|---|---|
| Price | $2.69 | $2.36 |
| Market cap | $216.7M | $218.8M |
| Today | 0.00% | +0.43% |
| 1 month | +5.9% | −21.1% |
| 6 months | +28.7% | −16.3% |
| Year to date | +49.4% | −33.7% |
| 1 year | +30.6% | −72.7% |
| Revenue growth (YoY) | +27.1% | — |
| Gross margin | 61.0% | — |
| Net margin | 19.0% | — |
| P/E (TTM) | 11.4× | — |
| Price / sales | 2.7× | — |
| Net cash | $40.7M | $118.3M |
| Dividend yield | — | — |
| Volatility (60d) | 43.8% | 67.0% |
| Short % of float | 3.8% | 16.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).